Evidence map›Paper›PMID 32528139›Full record

ReviewNature reviews. Gastroenterology & hepatology2020

SFED recommendations for IBD endoscopy during COVID-19 pandemic: Italian and French experience.

Federica Furfaro, Lucine Vuitton, Gionata Fiorino, Stephane Koch, Mariangela Allocca, Daniela Gilardi, Alessandra Zilli, Ferdinando D'Amico, Simona Radice, Jean-Baptiste Chevaux and 4 more

Open access · bronzeAbstract readReview
In one paragraph

Review in Nature reviews. Gastroenterology & hepatology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 1 pooled it
1.9field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 1 synthesis or guideline pooled it, 24 citations in OpenAlex.

  1. Pooled it
  2. Up-to-date literature review and issues of sedation during digestive endoscopy.Wideochirurgia i inne techniki maloinwazyjne = Videosurgery and other miniinvasive techniques · 2023
    Review
  3. Review
  4. COVID-19 induces gastrointestinal symptoms and affects patients' prognosis.The Journal of international medical research · 2022
    Review
  5. Review
  6. Endoscopy After the COVID-19 Pandemic-What Will Be Different?Current treatment options in gastroenterology · 2022
    Review
  7. Article
  8. Review
  9. Review
  10. Review
  11. Management of paediatric IBD after the peak of COVID-19 pandemic in Italy: A position paper on behalf of the SIGENP IBD working group.Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver · 2021
    Review
  12. Safety in Endoscopy for Patients and Healthcare Workers During the COVID-19 Pandemic.Techniques and innovations in gastrointestinal endoscopy · 2021
    Review
  13. Adapting to uncertainty.Nature reviews. Gastroenterology & hepatology · 2020
    Article
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 3 institutions in 2 countries.

Federica FurfaroIBD Center, Department of Gastroenterology, Humanitas Clinical and Research Center - IRCCS, Rozzano, Italy.
Lucine VuittonDepartment of Gastroenterology, Besançon University Hospital, Bourgogne-Franche-Comté University, Besançon, France.
Gionata FiorinoIBD Center, Department of Gastroenterology, Humanitas Clinical and Research Center - IRCCS, Rozzano, Italy.
Stephane KochDepartment of Gastroenterology, Besançon University Hospital, Bourgogne-Franche-Comté University, Besançon, France.
Mariangela AlloccaIBD Center, Department of Gastroenterology, Humanitas Clinical and Research Center - IRCCS, Rozzano, Italy.
Daniela GilardiIBD Center, Department of Gastroenterology, Humanitas Clinical and Research Center - IRCCS, Rozzano, Italy.
Alessandra ZilliIBD Center, Department of Gastroenterology, Humanitas Clinical and Research Center - IRCCS, Rozzano, Italy.
Ferdinando D'AmicoDepartment of Biomedical Sciences, Humanitas University, Pieve Emanuele, Italy.
Simona RadiceIBD Center, Department of Gastroenterology, Humanitas Clinical and Research Center - IRCCS, Rozzano, Italy.
Jean-Baptiste ChevauxDepartment of Gastroenterology and Inserm NGERE U1256, University Hospital of Nancy, University of Lorraine, Vandoeuvre-lès-Nancy, France.
Marion SchaeferDepartment of Gastroenterology and Inserm NGERE U1256, University Hospital of Nancy, University of Lorraine, Vandoeuvre-lès-Nancy, France.
Stanislas ChaussadeDepartment of Gastroenterology, Paris Cochin University Hospital APHP, Paris 5 University, Besançon, France.
Silvio DaneseIBD Center, Department of Gastroenterology, Humanitas Clinical and Research Center - IRCCS, Rozzano, Italy.ORCID http://orcid.org/0000-0001-7341-1351
Laurent Peyrin-BirouletDepartment of Gastroenterology and Inserm NGERE U1256, University Hospital of Nancy, University of Lorraine, Vandoeuvre-lès-Nancy, France. peyrinbiroulet@gmail.com.ORCID http://orcid.org/0000-0003-2536-6618
Humanitas University · ITInserm · FRUniversité Paris Cité · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The current coronavirus disease 2019 (COVID-19) pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection has required a complete change in the management of patients with inflammatory bowel disease (IBD) who need to undergo endoscopic procedures. Several preventive measures must be taken to avoid the spread of infection among health-care professionals and patients with IBD, including the use of personal protective equipment, greater attention to endoscopic room hygiene and rescheduling of non-urgent procedures. This Perspective aims to provide a guide based on the Italian and French experience to better face the difficulties encountered by endoscopists during this global health emergency. In particular, recommendations regarding the use of personal protective equipment to prevent COVID-19 transmission, both for patients and health-care professionals, are proposed and different scenarios in endoscopic IBD management are evaluated to suggest when endoscopy could be rescheduled and replaced by alternative biomarkers.

Indexed as

Endoscopy, GastrointestinalBetacoronavirusCoronavirus InfectionsCOVID-19Decision MakingFranceHumansInfectious Disease Transmission, Patient-to-ProfessionalInflammatory Bowel DiseasesItalyPandemicsPatient SelectionPersonal Protective EquipmentPneumonia, ViralSARS-CoV-2

Identifiers

PMID32528139
PMCPMC7288265
OpenAlexW3035529882

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.